Viewing SEC Facts Units
Company Name:
Enlivex Therapeutics Ltd.
CIK:
1596812
Start Filing Date:
2022-04-01
End Filing Date:
2022-06-30
ACCN:
0001213900-22-049873
Value:
$ 18,375,206
Value Error:
$ None
Created By:
Date Filed:
2022-08-22
FY:
2022
Fiscal Period:
Q2
Frame:
CY2021Q2
Type:
us-gaap
Form:
6-K
Units:
shares